Literature DB >> 3179166

Regionally selective cholinergic stimulation by BRL 24924 in the human isolated gut.

T A Burke1, G J Sanger.   

Abstract

1. The effects of BRL 24924 on cholinergic activity was studied in longitudinal muscle strips obtained from human stomach and colon (taenia). Contractions were evoked by exogenous acetylcholine (ACh) or by electrical field stimulation (EFS) of cholinergic neurones. Inhibitory nerve activity (predominantly non-adrenergic, non-cholinergic; NANC) was detected by measuring the relaxations evoked by EFS in the presence of atropine 1.4 microM. 2. In the stomach, BRL 24924 0.28-28 microM consistently increased the EFS-evoked contractions; lower concentrations (0.0028 and 0.028 microM) increased the contractions in most, but not all of the specimens studied. Since BRL 24924 28 microM did not affect NANC-mediated, EFS-evoked relaxations, and since high concentrations of BRL 24924 (28 and 282 microM) were required to increase ACh-evoked contractions, the increase in EFS-evoked contractions caused by BRL 24924 may be due to a facilitation of ACh release. 3. In the colon, BRL 24924 0.0028-282 microM did not affect EFS-evoked contractions. 4. BRL 24924 may therefore be regionally selective in its ability to stimulate human gastrointestinal cholinergic activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179166      PMCID: PMC1386537          DOI: 10.1111/j.1365-2125.1988.tb05275.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  The intrinsic innervation of the human alimentary tract and its relation to function.

Authors:  A Bennett; H L Stockley
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

2.  Relaxations mediated by adrenergic and non-adrenergic nerves in human isolated taenia coli.

Authors:  H L Stockley; A Bennett
Journal:  J Pharm Pharmacol       Date:  1977-09       Impact factor: 3.765

3.  The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.

Authors:  B Costall; S J Gunning; R J Naylor; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

4.  Modification of electrical field stimulation-induced contractions in the guinea-pig ileum by metoclopramide and ICS 205-930 depends on the integrity of the mucosa.

Authors:  B Costall; S J Gunning; R J Naylor; F D Tattersall
Journal:  J Pharm Pharmacol       Date:  1986-11       Impact factor: 3.765

5.  5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo.

Authors:  K H Buchheit; B Costall; G Engel; S J Gunning; R J Naylor; B P Richardson
Journal:  J Pharm Pharmacol       Date:  1985-09       Impact factor: 3.765

6.  Effects of metoclopramide and domperidone on cholinergically mediated contractions of human isolated stomach muscle.

Authors:  G J Sanger
Journal:  J Pharm Pharmacol       Date:  1985-09       Impact factor: 3.765

7.  Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism.

Authors:  W D Miner; G J Sanger
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

8.  Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.

Authors:  G J Sanger
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

9.  Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret.

Authors:  P L Andrews; J Hawthorn
Journal:  Neuropharmacology       Date:  1987-09       Impact factor: 5.250

10.  Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.

Authors:  W D Miner; G J Sanger; D H Turner
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

View more
  4 in total

1.  Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

Review 2.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Human pharmacology of renzapride: a new gastrokinetic benzamide without dopamine antagonist properties.

Authors:  D H Staniforth; M Pennick
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.

Authors:  Nicholas L Meyers; Roger I Hickling
Journal:  Drugs R D       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.